Analytical Data
-
基因名
ABHD13
- Application
-
别名
ABHD13; C13orf6; Protein ABHD13; Alpha/beta hydrolase domain-containing Protein 13
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q7L211
-
表达区间
1-337aa
-
氨基酸序列
MEKSWMLWNFVERWLIALASWSWALCRISLLPLIVTFHLYGGIILLLLIFISIAGILYKFQDVLLYFPEQPSSSRLYVPMPTGIPHENIFIRTKDGIRLNLILIRYTGDNSPYSPTIIYFHGNAGNIGHRLPNALLMLVNLKVNLLLVDYRGYGKSEGEASEEGLYLDSEAVLDYVMTRPDLDKTKIFLFGRSLGGAVAIHLASENSHRISAIMVENTFLSIPHMASTLFSFFPMRYLPLWCYKNKFLSYRKISQCRMPSLFISGLSDQLIPPVMMKQLYELSPSRTKRLAIFPDGTHNDTWQCQGYFTALEQFIKEVVKSHSPEEMAKTSSNVTII
-
分子量
38.5 KDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Recombinant Human ABHD12 Protein，His
Cat：PA2000-5304
Recombinant Human NUDT11 Protein，His
Cat：PA2000-9812
Protein Description
ABHD13 (Abhydrolase Domain Containing 13) is a member of the serine hydrolase family, playing a crucial role in the regulation of lipid metabolism and cellular signaling pathways. It is believed to be involved in the hydrolysis of bioactive lipids, thereby influencing numerous physiological processes such as inflammation, neuroprotection, and energy homeostasis. Recent studies have highlighted its potential implications in various pathological conditions, including obesity, diabetes, and neurodegenerative diseases. The functional characterization of ABHD13, particularly through the production of recombinant proteins, has gained significant attention as it allows for a deeper understanding of its enzymatic activity, substrate specificity, and regulatory mechanisms. By utilizing recombinant DNA technology, researchers can express and purify ABHD13 in a controlled environment, facilitating kinetic studies and the exploration of its interactions with small molecules, making it a promising target for drug discovery and therapeutic intervention. Understanding the structure-function relationship of ABHD13 through recombinant protein expression may pave the way for novel approaches in treating diseases linked to lipid dysregulation. Thus, the study of ABHD13 recombinant proteins not only enhances our basic scientific knowledge but also holds potential for translational applications in medicine.
